期刊文献+

肾上腺腺瘤中KCNJ5基因体细胞突变的研究进展 被引量:1

Research Advance in KCNJ5 Gene Somatic Mutations in Patients with Aldosterone-producing Adenoma
下载PDF
导出
摘要 肾上腺腺瘤为原发性醛固酮增多症的一种常见病因,人类KCNJ5基因编码G蛋白偶联的内向整流型钾通道(GIRK4)蛋白,肾上腺腺瘤组织中KCNJ5基因突变导致GIRK4蛋白结构和功能发生改变,GIRK4蛋白通道离子选择性缺失,且突变型与野生型临床表型之间的差异比较结果提示突变型临床表型更严重。目前已有多项研究发现肾上腺腺瘤患者中KCNJ5基因存在多种体细胞突变,这些突变可能与肾上腺腺瘤的发生、发展密切相关,原发性醛固酮增多症可能存在更多的临床亚型。 Aldosterone-producing adenoma is a common cause of primary aldosteronism. KCNJ5 gene codes G protein gated inward rectifier K + channel 4 ( GIRK4 ), the alter of which can lead to the changes of structure and function of GIRK4 in aldosterone-producing adenoma,and GIRK4 protein ion channel selectivity missing. The subjects with mutations had more serious condition than subjects without mutations after compa- ring their clinical phenotype. To date, a number of studies found KCNJ5 gene somatic mutations existence in patients with aldosterone-producing adenoma. These mutations may have close relationships with the develop- ment of aldosterone-producing adenoma. And primary aldosteronism may have more clinical subtypes.
作者 邵丹 李南方
出处 《医学综述》 2014年第2期242-244,共3页 Medical Recapitulate
基金 国家自然科学基金(81160109)
关键词 肾上腺腺瘤 KCNJ5基因 体细胞突变 Aldosterone-producing adenoma KCNJ5 Gene Somatic mutations
  • 相关文献

参考文献23

  • 1Funder JW,Carey RM,Fardella C. Case detection,diagnosis,and treatmentof patients with primary aldosteronism[J].{H}Journal of Clinical Endocrinology and Metabolism,2008,(9):3266-3281.
  • 2Calhoun DA,Nishizaka MK,Zaman MA. High prevalence ofprimary aldosteronism among black and white subjects with resistant hypertension[J].{H}HYPERTENSION,2002,(6):892-896.
  • 3李南方,李红建,王红梅,王新玲,祖菲亚,张德莲,常桂娟,努尔古丽,周克明,骆琴,王梦卉,胡君丽,王磊.330例原发性醛固酮增多症患者的临床分析[J].中华内分泌代谢杂志,2011,27(9):752-754. 被引量:31
  • 4Mulatero P,Stowasser M,Loh KC. Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J].{H}Journal of Clinical Endocrinology and Metabolism,2004,(3):1045-1050.
  • 5Young WF Jr. Minireview:primary aldosteronismchanging concepts in diagnosis and treatment[J].{H}ENDOCRINOLOGY,2003,(6):2208-2213.
  • 6Choi M,Scholl UI,Yue P. 2011 K+ Channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension[J].{H}SCIENCE,2011,(6018):768-772.
  • 7徐向华,王晓良.中枢神经系统中与G蛋白偶联的内向整流钾通道[J].生理科学进展,2001,32(2):168-170. 被引量:2
  • 8Bradley KK,Hatton WJ,Mason HS. Kir3.1/3.2 encodes an I(KACh)-like current in gastrointestinal myocytes[J].{H}American Journal of Physiology Gastrointestinal and Liver Physiology,2000,(2):G289-G296.
  • 9Brundel BJ,Van Gelder IC,Henning RH. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation[J].{H}CIRCULATION,2001,(5):684-690.
  • 10Weigl LG,Schreibmayer W. G-protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics[J].{H}Molecular Pharmacology,2001,(2):282-289.

二级参考文献19

  • 1张惠兰,刘振江,邵娇梅,严江涛,汪道文.血浆醛固酮/肾素活性比值在诊断原发性醛固酮增多症患者的价值[J].中华心血管病杂志,2006,34(10):873-876. 被引量:17
  • 2Calhoun DA.Aldosteronism and hypertension.Clin J Am Soc Nephrol,2006,1:1039-1045.
  • 3Catena C,Colussi G,Nadalini E,et al.Cardiovascular outcomes in patients with primary aldosteronism after treatment.Arch Intern Med,2008,168:80-85.
  • 4Sechi LA,Novello M,Lapenna R,et al.Long-term renal outcomes in patients with primary aldosteronism.JAMA,2006,295:2638-2645.
  • 5Funder JW,Carey RM,Fardella C,et al.Case detection,diagnosis,and treatment of patients with primary aldosteronism:an endocrine society clinical practice guideline.J Clin Endocrinol Metab,2008,93:3266-3281.
  • 6Bauersachs J,Heck M,Fraccarollo D,et al.Addition of spironolactone to angiotensin——converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction:role of vascular superoxide anion formation and endothelial nitric oxide synthase expression.J Am Coll Cardiol,2002,39:351-358.
  • 7Duprez DA.Aldosterone and the vasculature:mechanisms mediating resistant hypertension.J Clin Hypertens (Greenwich),2007,9 (suppl 1):13-18.
  • 8Mulatero P,Stowasser M,Loh K,et al.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents.J Clin Endocrinol Metab,2004,89:1045-1050.
  • 9Gordon RD,Stowasser M,Klemm SA,et al.Primary aldosteronism some genetic,morphological,and biochemical aspects of subtypes.Steroids,1995,60:35-41.
  • 10Gordon RD,Laragh JH,Funder JW,et al.Low renin hypertensive states:perspectives, unsolved problems,future research. Trends Endocrinol Metab,2005,16:108-113.

共引文献31

同被引文献12

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部